Varaico: Literature-Extracted Genetic Variants

Gene:CACNA1A
Variant:p.V1396M
Back to variants list

CACNA1A

NM_023035.3:p.V1396M

Associated Papers

Expanding the phenotypic spectrum of CACNA1A-related developmental and epileptic encephalopathy in adults.

Palumbo O et al.

Epileptic Disorders : International Epilepsy Journal With Videotape, 2026

Shared genetics in epilepsy and migraine: A scoping review.

Sahu P et al.

Epileptic Disorders : International Epilepsy Journal With Videotape, 2025

Genetic testing in cerebral palsy with clinical and neuroimaging variables.

Tantsis EM et al.

Developmental Medicine and Child Neurology, 2025

40186422 (PubMed )
Supplement: DMCN-67-1443-s005.pdf

Clinically relevant variants detected in Chinese children with global developmental delay/intellectual disability: An exome-wide sequencing study.

Qiao Y et al.

Genes & Diseases, 2025

40212794 (PubMed )
Supplement: mmc2.xlsx › Sheet1

Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments.

Cheerie D et al.

American Journal of Human Genetics, 2025

40139194 (PubMed )
Supplement: mmc2.pdf

Phenotypic variability in cases with CACNA1A mutation.

Bozkaya-Yilmaz S et al.

European Journal of Pediatrics, 2025

A Longitudinal Exploration of CACNA1A -related Hemiplegic Migraine in Children.

Schaare D et al.

Medrxiv : the Preprint Server for Health Sciences, 2024

A Review of the CACNA Gene Family: Its Role in Neurological Disorders.

Szymanowicz O et al.

Diseases (basel, Switzerland), 2024

The genotype-phenotype correlations of the CACNA1A-related neurodevelopmental disorders: a small case series and literature reviews.

Kessi M et al.

Frontiers in Molecular Neuroscience, 2023

Clinical and genetic characterization of CACNA1A-related disease.

Lipman AR et al.

Clinical Genetics, 2022

The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies.

Leduc-Pessah H et al.

Genes, 2022

Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study.

Schon KR et al.

Bmj (clinical Research Ed.), 2021

CACNA1A Mutations Causing Early Onset Ataxia: Profiling Clinical, Dysmorphic and Structural-Functional Findings.

Martínez-Monseny AF et al.

International Journal of Molecular Sciences, 2021

From Genotype to Phenotype: Expanding the Clinical Spectrum of CACNA1A Variants in the Era of Next Generation Sequencing.

Indelicato E et al.

Frontiers in Neurology, 2021

De novo mutations in folate-related genes associated with common developmental disorders.

Luo T et al.

Computational and Structural Biotechnology Journal, 2021

33777337 (PubMed )
Supplement: mmc6.xlsx › Sheet1

CACNA1A Gene Variants in Eight Chinese Patients With a Wide Range of Phenotypes.

Zhang L et al.

Frontiers in Pediatrics, 2020

Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome.

Jiang X et al.

Epilepsia, 2019

Use of a Dynamic Genetic Testing Approach for Childhood-Onset Epilepsy.

Balciuniene J et al.

Jama Network Open, 2019

Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia.

Travaglini L et al.

European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society, 2017

Adult-onset Migraine and Very Late Onset Ataxia Due to a Novel Pathogenic Variant of the CACNA1A Gene.

Bhattacharjee S et al.

Neurology India, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."